Mehmet Karaca Selected Research

Mehmet Karaca Research Topics

Disease

4	Reperfusion Injury 08/2016 - 12/2008
4	Inflammation (Inflammations) 08/2016 - 04/2011
4	Ischemia 08/2016 - 12/2008
4	Neoplasms (Cancer) 01/2015 - 10/2004
3	ST Elevation Myocardial Infarction 03/2016 - 08/2014
2	Breast Neoplasms (Breast Cancer) 10/2004 - 01/2004
1	Mucopolysaccharidosis VI (Syndrome, Maroteaux-Lamy) 11/2017
1	Coma (Comas) 03/2016
1	Heart Arrest (Cardiac Arrest) 03/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2016
1	Asthma (Bronchial Asthma) 01/2016
1	Myocardial Infarction 12/2015
1	Biotinidase Deficiency (Multiple Carboxylase Deficiency, Late Onset) 08/2015
1	Vascular Diseases (Vascular Disease) 04/2015
1	Genetic Predisposition to Disease (Genetic Predisposition) 04/2015
1	Prostatic Neoplasms (Prostate Cancer) 01/2015
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2014
1	Homocystinuria 01/2014
1	Neural Tube Defects (Exencephaly) 01/2013
1	Diabetes Mellitus 11/2012
1	Diarrhea 12/2011
1	Epilepsy (Aura) 05/2010
1	Ulcer 04/2009
1	HELLP Syndrome 08/2008
1	Hemolysis 08/2008
1	Ovarian Torsion 06/2008
1	Infections 06/2002

Drug/Important Bio-Agent (IBA)

3	AntioxidantsIBA 08/2016 - 06/2009
3	salicylhydroxamic acid (SHAM)IBA 03/2010 - 12/2008
2	Protective AgentsIBA 08/2016 - 06/2009
2	DNA (Deoxyribonucleic Acid)IBA 08/2015 - 10/2004
2	Hormones (Hormone)IBA 04/2015 - 04/2009
2	Adenosine Triphosphatases (ATPase)IBA 04/2014 - 01/2004
2	EnzymesIBA 12/2011 - 08/2008
2	Tamoxifen FDA LinkGeneric 04/2011 - 04/2009
2	Estrogens (Estrogen)FDA Link 05/2010 - 04/2009
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 03/2010 - 12/2008
1	Lysergic Acid Diethylamide (LSD)IBA 11/2017
1	Renin InhibitorsIBA 08/2016
1	aliskiren FDA Link 08/2016
1	CytokinesIBA 08/2016
1	HDL LipoproteinsIBA 02/2016
1	omega-Chloroacetophenone (Mace)IBA 02/2016
1	Indicators and Reagents (Reagents)IBA 02/2016
1	Interleukin-4 (Interleukin 4)IBA 01/2016
1	BiotinidaseIBA 08/2015
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2015
1	Androgen Receptors (Androgen Receptor)IBA 01/2015
1	AndrogensIBA 01/2015
1	Histone Deacetylase InhibitorsIBA 04/2014
1	A-Form DNA (A-DNA)IBA 04/2014
1	MethyltransferasesIBA 04/2014
1	Cystathionine beta-Synthase (Serine Sulfhydrase)IBA 01/2014
1	SulfurIBA 01/2014
1	AntigensIBA 01/2013
1	CarbohydratesIBA 01/2013
1	Carcinoembryonic AntigenIBA 01/2013
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2013
1	CreatinineIBA 11/2012
1	ImmunosorbentsIBA 12/2011
1	AntibodiesIBA 12/2011
1	CarrageenanIBA 04/2011
1	Peroxidase (Myeloperoxidase)IBA 03/2010
1	OxidesIBA 03/2010
1	Telmisartan (Micardis)FDA Link 03/2010
1	Erythropoietin FDA Link 06/2009
1	PiperoxanIBA 04/2009
1	Indomethacin (Indometacin)FDA LinkGeneric 04/2009
1	Yohimbine (Yocon)IBA 04/2009
1	Estradiol (Delestrogen)FDA LinkGeneric 04/2009
1	alpha-2 Adrenergic ReceptorsIBA 04/2009
1	Amlodipine (Norvasc)FDA LinkGeneric 12/2008
1	Nitric Oxide Synthase (NO Synthase)IBA 12/2008
1	Superoxide DismutaseIBA 12/2008
1	Phenobarbital (Luminal)FDA Link 10/2004
1	Estrogen ReceptorsIBA 10/2004
1	Ribosomal Proteins (Ribosomal Protein)IBA 01/2004
1	splicing factor 3aIBA 01/2004
1	Glyceraldehyde-3-Phosphate Dehydrogenases (GAPD)IBA 01/2004
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2004
1	Messenger RNA (mRNA)IBA 06/2002
1	Complementary DNA (cDNA)IBA 06/2002

Therapy/Procedure

2	Percutaneous Coronary Intervention 02/2016 - 08/2014
2	Conservative Treatment 12/2008 - 06/2008
1	Enzyme Replacement Therapy 11/2017
1	Induced Hypothermia 03/2016
1	Myocardial Revascularization 12/2015
1	Therapeutics 01/2013